Kitch Wilson
Investitore di Private Equity presso Pioneer Fund/NY/
Posizioni attive di Kitch Wilson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Investitore di Private Equity | 01/10/2023 | - |
Storia della carriera di Kitch Wilson
Precedenti posizioni note di Kitch Wilson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Bell Biosystems, Inc.
 Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Consulente / Consigliere | 01/01/2011 | 01/04/2014 |
Formazione di Kitch Wilson
| Stanford University | Graduate Degree |
| Duke University School of Medicine | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Graduate Degree | 2 |
| Private Equity Investor | 1 |
| Consultant / Advisor | 1 |
Settori
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Bell Biosystems, Inc.
Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Kitch Wilson
- Esperienza
